Cargando…

GMP-conformant on-site manufacturing of a CD133(+) stem cell product for cardiovascular regeneration

BACKGROUND: CD133(+) stem cells represent a promising subpopulation for innovative cell-based therapies in cardiovascular regeneration. Several clinical trials have shown remarkable beneficial effects following their intramyocardial transplantation. Yet, the purification of CD133(+) stem cells is ty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skorska, Anna, Müller, Paula, Gaebel, Ralf, Große, Jana, Lemcke, Heiko, Lux, Cornelia A., Bastian, Manuela, Hausburg, Frauke, Zarniko, Nicole, Bubritzki, Sandra, Ruch, Ulrike, Tiedemann, Gudrun, David, Robert, Steinhoff, Gustav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303262/ https://www.ncbi.nlm.nih.gov/pubmed/28187777 http://dx.doi.org/10.1186/s13287-016-0467-0

Ejemplares similares

Mechanisms of stem cell based cardiac repair-gap junctional signaling promotes the cardiac lineage specification of mesenchymal stem cells
por: Lemcke, Heiko, et al.
Publicado: (2017)

Angiogenic Potential of Bone Marrow Derived CD133(+) and CD271(+) Intramyocardial Stem Cell Trans- Plantation Post MI
por: Sasse, Sarah, et al.
Publicado: (2019)

Dose-Independent Therapeutic Benefit of Bone Marrow Stem Cell Transplantation after MI in Mice
por: Zarniko, Nicole, et al.
Publicado: (2020)

Magnet-Bead Based MicroRNA Delivery System to Modify CD133(+) Stem Cells
por: Müller, Paula, et al.
Publicado: (2016)

Selective Migration of Subpopulations of Bone Marrow Cells along an SDF-1α and ATP Gradient
por: Laupheimer, Michael, et al.
Publicado: (2014)

Data on the fate of MACS® MicroBeads intramyocardially co-injected with stem cell products
por: Müller, Paula, et al.
Publicado: (2017)

The Effects of Hypoxic Preconditioned Murine Mesenchymal Stem Cells on Post-Infarct Arrhythmias in the Mouse Model
por: Ahmad, Beschan, et al.
Publicado: (2022)

CD271(+) Human Mesenchymal Stem Cells Show Antiarrhythmic Effects in a Novel Murine Infarction Model
por: Sadraddin, Haval, et al.
Publicado: (2019)

Cardiac Function Improvement and Bone Marrow Response –: Outcome Analysis of the Randomized PERFECT Phase III Clinical Trial of Intramyocardial CD133(+) Application After Myocardial Infarction
por: Steinhoff, Gustav, et al.
Publicado: (2017)

Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart
por: Klopsch, Christian, et al.
Publicado: (2018)

Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles
por: Schade, Anna, et al.
Publicado: (2013)

Cardiomyocyte Transplantation after Myocardial Infarction Alters the Immune Response in the Heart
por: Vasudevan, Praveen, et al.
Publicado: (2020)

Magnetic Nanoparticle Based Nonviral MicroRNA Delivery into Freshly Isolated CD105(+) hMSCs
por: Schade, Anna, et al.
Publicado: (2014)

Recent Progress in Stem Cell Modification for Cardiac Regeneration
por: Lemcke, Heiko, et al.
Publicado: (2018)

CCR2 macrophage response determines the functional outcome following cardiomyocyte transplantation
por: Vasudevan, Praveen, et al.
Publicado: (2023)

Human Mesenchymal Stem Cells Display Reduced Expression of CD105 after Culture in Serum-Free Medium
por: Mark, Peter, et al.
Publicado: (2013)

The CD4(+)AT2R(+) T cell subpopulation improves post-infarction remodelling and restores cardiac function
por: Skorska, Anna, et al.
Publicado: (2015)

Validating intramyocardial bone marrow stem cell therapy in combination with coronary artery bypass grafting, the PERFECT Phase III randomized multicenter trial: study protocol for a randomized controlled trial
por: Donndorf, Peter, et al.
Publicado: (2012)

Dental follicle progenitor cells responses to Porphyromonas gingivalis LPS
por: Chatzivasileiou, Kyriaki, et al.
Publicado: (2013)

Quantitative Evaluation of the Sarcomere Network of Human hiPSC-Derived Cardiomyocytes Using Single-Molecule Localization Microscopy
por: Lemcke, Heiko, et al.
Publicado: (2020)

18F-FDG PET-Based Imaging of Myocardial Inflammation Predicts a Functional Outcome Following Transplantation of mESC-Derived Cardiac Induced Cells in a Mouse Model of Myocardial Infarction
por: Vasudevan, Praveen, et al.
Publicado: (2019)

Targeted Delivery of Human VEGF Gene via Complexes of Magnetic Nanoparticle-Adenoviral Vectors Enhanced Cardiac Regeneration
por: Zhang, Yue, et al.
Publicado: (2012)

GMP/ISO quality audit manual for healthcare manufacturers and their suppliers /
por: Steinborn, Leonard
Publicado: (2003)

The Individual Effects of Cyclin-Dependent Kinase Inhibitors on Head and Neck Cancer Cells—A Systematic Analysis
por: Schoenwaelder, Nina, et al.
Publicado: (2021)

Cell-based medicinal products and the development of GMP-compliant processes and manufacturing
por: Romagnoli, Luca, et al.
Publicado: (2011)

Good Manufacturing Practice (GMP) Compliance for Phage Therapy Medicinal Products
por: Bretaudeau, Laurent, et al.
Publicado: (2020)

GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR
por: Straetemans, Trudy, et al.
Publicado: (2018)

Moving analytical ultracentrifugation software to a good manufacturing practices (GMP) environment
por: Savelyev, Alexey, et al.
Publicado: (2020)

Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of Experience
por: Balcerek, Joanna, et al.
Publicado: (2021)

Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer
por: Anyakora, Chimezie, et al.
Publicado: (2017)

GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy
por: Gaipa, Giuseppe, et al.
Publicado: (2010)

Combined Gemcitabine and Immune-Checkpoint Inhibition Conquers Anti-PD-L1 Resistance in Low-Immunogenic Mismatch Repair-Deficient Tumors
por: Salewski, Inken, et al.
Publicado: (2021)

Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin
por: Kargbo, Robert B., et al.
Publicado: (2020)

Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance
por: Nath, Suman C., et al.
Publicado: (2020)

Acceleration of Translational Mesenchymal Stromal Cell Therapy Through Consistent Quality GMP Manufacturing
por: Jayaraman, Premkumar, et al.
Publicado: (2021)

Cell Origin of Human Mesenchymal Stem Cells Determines a Different Healing Performance in Cardiac Regeneration
por: Gaebel, Ralf, et al.
Publicado: (2011)

Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU
por: Souto, Eliana B., et al.
Publicado: (2020)

cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications
por: Baghbaderani, Behnam Ahmadian, et al.
Publicado: (2015)

GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy
por: Fernández, Lucía, et al.
Publicado: (2019)

First-in-human PeriCord cardiac bioimplant: Scalability and GMP manufacturing of an allogeneic engineered tissue graft
por: Prat-Vidal, Cristina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0lsvbo7bnl9gj0kahr6ntvdb79